Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-009348
Filing Date
2022-09-06
Accepted
2022-09-06 16:10:03
Documents
1
Period of Report
2022-09-01

Document Format Files

Seq Description Document Type Size
1 form4-09062022_010947.html 4  
1 form4-09062022_010947.xml 4 11755
  Complete submission text file 0001415889-22-009348.txt   13136
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Issuer) CIK: 0001730430 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KINIKSA PHARMACEUTICALS CORP. 100 HAYDEN AVENUE LEXINGTON MA 02421
Business Address
Ragosa Mark (Reporting) CIK: 0001835458 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38492 | Film No.: 221228353